GE's Lombardo lands at ALI as company forms U.S. unitPACS veteran Tony Lombardo didn't take long to find a new job. Ultrasound miniPACS developer ALI Technologies has tapped Lombardo to head up ALI Imaging Systems, a wholly owned subsidiary that
PACS veteran Tony Lombardo didn't take long to find a new job. Ultrasound miniPACS developer ALI Technologies has tapped Lombardo to head up ALI Imaging Systems, a wholly owned subsidiary that will serve as the Richmond, British Columbia-based firm's U.S. field sales organization. ALI Imaging Systems will be based near Milwaukee, WI.
Lombardo, who left his post as general manager of sales for the Integrated Imaging Solutions division of GE Medical Systems in June (PNN 7/98), will assume the title of president of ALI Imaging Systems and vice president of ALI Technologies. He will also be joined by another former GE employee in ALI's executive ranks.
John LaLonde, who recently served as global engineering manager in the IIS division, has been named vice president of technology. LaLonde left GE in early 1998 and then served as vice president of Aksys, a developer of home hemodialysis products.
In other personnel moves, president Chris Hanna has left the company to join the Mayo Clinic as an expert in radiology informatics. Upon Hanna's departure on August 31, CEO Greg Peet will add the duties and title of president to his responsibilities. Hanna, who cofounded ALI, will continue to serve on the company's board of directors.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.